Person

Alfred Sandrock

Formerly Head of Research & Development, Biogen

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$6.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • BIIB
    Biogen
    Head of Research & Development
    2016 or earlier – last filing Jun 2021

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 7, 2021BIIBSale7,672$440.00$3.4M
Nov 4, 2020BIIBSale1,500$350.00$525K
Feb 27, 2018BIIBSale259$290.83$75K
Feb 23, 2018BIIBSale908$293.44$266K
Feb 20, 2018BIIBSale743$292.00$217K
Feb 15, 2018BIIBSale1,294$298.85$387K
Apr 3, 2017BIIBSale1,981$274.08$543K
Mar 1, 2017BIIBSale973$290.07$282K
Feb 25, 2016BIIBSale183$261.90$48K
Feb 17, 2016BIIBSale722$256.16$185K
Feb 9, 2016BIIBSale852$246.54$210K

SEC reporting-owner ID (CIK) 1577061 · all filings on EDGAR

Alfred Sandrock | USBoard